A phase II study of the combination apatinib with VP16 in heavily pre-treated recurrent epithelial ovarian cancer patients
Latest Information Update: 16 Apr 2018
At a glance
- Drugs Etoposide (Primary) ; Rivoceranib (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
Most Recent Events
- 16 Apr 2018 New trial record